Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Genetic

Explore clinical trials studying Skin Diseases, Genetic. Study availability and eligibility vary by location and protocol.

1,834 public trials 277 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Genetic trial results

Completed

A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis

NCT03334435

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • CEDIC-Centro de Investigaciones Clinicas Caba, Buenos Aires, Argentina
  • Centro de Investigaciones Metabólicas (CINME) Buenos Aires, Argentina
  • Buenos Aires Skin Ciudad Autonoma Buenos Aires, Argentina
  • Fundacion CIDEA Ciudad Autonoma Buenos Aires, Argentina
View all 185 locations
View Trial Details
Completed

A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita

NCT05180708

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations
  • Stanford University Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • Park Avenue Dermatology Orange Park, Florida, United States
  • Minnesota Clinical Study Center Fridley, Minnesota, United States
View Trial Details
Completed

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita

NCT04520750

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Minnesota Clinical Study Center Fridley, Minnesota, United States
  • University of Utah Murray, Utah, United States
View Trial Details
Completed

Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita

NCT03920228

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • International Dermatology Research Miami, Florida, United States
View Trial Details

Related conditions